Chief Commercial Officer (CCO)
Andrew has over 10 years’ experience in the pharmaceutical industry. Following completion of his PhD, Andrew joined Onyx Scientific as a development chemist before moving into a business development role in 2006. In 2010 Andrew joined Aesica Pharmaceuticals where he held various positions in sales & marketing, project management and corporate development. Andrew joined Shasun Pharma Solutions in July 2015 and is now responsible for all commercial activities at Sterling.